Showing results (571-580 of 610) with videos related to
Sort By:
Pageof 61
Viruses|August 26, 2023
Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV StudyGregory Morgan, Selina Casalino, Sunakshi Chowdhary, et al.Human Mutation|July 16, 2015
Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan SyndromeViviana Cordeddu, Jiani C Yin, Cecilia Gunnarsson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future ApplicationsKenneth C Anderson, Daniel Auclair, Gary J Kelloff, et al.Cancer Discovery|October 24, 2023
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNADerek Wong, Ping Luo, Leslie E Oldfield, et al.Med (New York, N.Y.)|August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trialsAlberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.American Journal of Human Genetics|August 16, 2006
Oligonucleotide microarray analysis of genomic imbalance in children with mental retardationJ M Friedman, Agnes Baross, Allen D Delaney, et al.Nature|November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomesShu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.Nature Cancer|February 5, 2022
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneityLaura M Richards, Owen K N Whitley, Graham MacLeod, et al.Nature|August 31, 2017
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchyXiaoyang Lan, David J Jörg, Florence M G Cavalli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.Pageof 61